GSK-AC2110664

Study Sponsor: GSK

Study Title

Dose-Ranging Study for GSK233705B Delivered Once Daily in Subjects with COPD

Medicine or Vaccine (generic name)

darotropium bromide

Sponsor Identification Number

AC2110664

Trial Registry Identification Number(#'s)

NCT00676052 2007-006287-29

Medical Condition

Pulmonary Disease, Chronic Obstructive

Phase

Phase 2

Link to study details on the GSK Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

May 2013